Brian C Stephenson Bridge Bio Pharma, Inc. (BBIO) insider trading activity

Brian C Stephenson is Secretary, Treasurer & CFO of BridgeBio Pharma, Inc.. Currently has a direct ownership of 93,758 shares of BBIO, which is worth approximately $2.2 Million. The most recent transaction as insider was on Feb 03, 2023, when has been sold 61,040 shares (Common Stock) at a price of $11.01 per share, resulting in proceeds of $672,050. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 93.8K

10.05% 3M change

155.4% 12M change

Total Value Held $2.2 Million

BRIAN C STEPHENSON Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 03 2023	SELL Open market or private sale	$672,050 $11.01 p/Share	61,040 Reduced 21.78%	219,184 Common Stock
Jan 05 2023	SELL Open market or private sale	$468,176 $7.67 p/Share	61,040 Reduced 17.89%	280,224 Common Stock
Nov 17 2022	SELL Open market or private sale	$184,973 $9.4 p/Share	19,678 Reduced 5.45%	341,264 Common Stock
Nov 16 2022	SELL Payment of exercise price or tax liability	$104,005 $9.64 p/Share	10,789 Reduced 2.9%	360,942 Common Stock
Nov 16 2022	BUY Exercise of conversion of derivative security	-	30,467 Added 7.58%	371,731 Common Stock
Aug 16 2022	SELL Payment of exercise price or tax liability	$102,235 $11.08 p/Share	9,227 Reduced 2.63%	341,260 Common Stock
Aug 16 2022	BUY Exercise of conversion of derivative security	-	26,680 Added 7.07%	350,487 Common Stock
May 16 2022	SELL Payment of exercise price or tax liability	$62,197 $6.74 p/Share	9,228 Reduced 2.77%	323,807 Common Stock
May 16 2022	BUY Exercise of conversion of derivative security	-	26,680 Added 7.42%	333,035 Common Stock
Feb 16 2022	SELL Payment of exercise price or tax liability	$9,017 $8.84 p/Share	1,020 Reduced 0.33%	306,355 Common Stock
Feb 16 2022	BUY Exercise of conversion of derivative security	-	2,488 Added 0.8%	307,375 Common Stock
Nov 16 2021	SELL Payment of exercise price or tax liability	$58,306 $47.25 p/Share	1,234 Reduced 0.4%	304,382 Common Stock
Nov 16 2021	BUY Exercise of conversion of derivative security	-	2,488 Added 0.81%	305,616 Common Stock
Aug 16 2021	SELL Payment of exercise price or tax liability	$50,865 $49.48 p/Share	1,028 Reduced 0.34%	303,128 Common Stock
Aug 16 2021	BUY Exercise of conversion of derivative security	-	2,487 Added 0.81%	304,156 Common Stock
May 16 2021	SELL Payment of exercise price or tax liability	$46,255 $53.66 p/Share	862 Reduced 0.28%	301,669 Common Stock
May 16 2021	BUY Exercise of conversion of derivative security	-	2,488 Added 0.82%	302,531 Common Stock
Feb 17 2021	BUY Open market or private purchase	$500,000 $62.5 p/Share	8,000 Added 2.6%	300,043 Common Stock
Feb 16 2021	SELL Payment of exercise price or tax liability	$38,468 $64.98 p/Share	592 Reduced 0.2%	292,043 Common Stock
Feb 16 2021	BUY Exercise of conversion of derivative security	-	1,710 Added 0.58%	292,635 Common Stock
Nov 16 2020	SELL Payment of exercise price or tax liability	$26,243 $44.33 p/Share	592 Reduced 0.2%	290,085 Common Stock
Nov 16 2020	BUY Exercise of conversion of derivative security	-	1,710 Added 0.58%	290,677 Common Stock

BCS

Brian C Stephenson

Secretary, Treasurer & CFO

Palo Alto, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BBIO shares.

Notify only if

Value

Insider Trading

Get notified when an Bridge Bio Pharma, Inc. insider buys or sells BBIO shares.

Notify only if

Operation

Value

Type

News

Receive news related to BridgeBio Pharma, Inc.

Track Activities on BBIO

Account